The occurrence and antibiotic resistance pattern of Klebsiella isolates in burn patients in the North of Iran

Meysam Hasannejad-Bibalan, Ali Asqar Arabshahi, Nazanin Fathi, Mahsa Sadeghi, Tofigh Yaghoubi, Mohammadreza Mobayen, Reyhaneh Bonyad, Hadi Sedigh Ebrahim-Saraie

Abstract


Klebsiella species are one the common bacterial etiology of burn related infections that may cause serious life threaten complications in patients. Antibiotic resistance challenge in recent years associated with increased mortality and treatment costs. Therefore, in order to optimize infection control policy and help with epidemiological data, the present study investigates the occurrence and antibiotic resistance pattern of Klebsiella isolates in burn patients in the North of Iran. This descriptive cross-sectional study was performed on burn patients hospitalized from March 2018 to March 2021 at Velayat Subspecialty Burn and Plastic Surgery Hospital in Rasht, the North of Iran. Standard microbiological producers were applied for the isolation and identification of Klebsiella isolates. Antibiotic resistance patterns were determined using the disk diffusion method. Of 594 clinical specimens, 61 cases (10.3%) were positive for Klebsiella. Among them, 42 samples (68.9%) were collected from intensive care units (ICUs) and 19 cases (31.1%) from internal wards. Also, 5 patients (8.2%) were related to ventilator-associated pneumonia (VAP). The highest level of antimicrobial resistance in Klebsiella isolates was toward imipenem (85.7%) and gentamicin (69.1%), respectively. While the highest level of susceptibility was to meropenem (63.6%). Regarding the significant prevalence and antibiotic resistance of in Klebsiella isolates among burn patients, more strict infection treatment protocols based on laboratory results can prevent increased antibiotic resistance.


Keywords


Antibiotic resistance; Burn; Klebsiella pneumoniae; Nosocomial infection

Full Text:

Full-text PDF

References


Revelas A. Healthcare - associated infections: A public health problem. Niger Med J. 2012;53(2):59-64. DOI: 10.4103/0300-1652.103543 PMID: 23271847

Nimer NA. Nosocomial Infection and Antibiotic-Resistant Threat in the Middle East. Infect Drug Resist. 2022;15:631-9. DOI: 10.2147/idr.s351755 PMID: 35241915

Sikora A, Zahra F. Nosocomial Infections. StatPearls. Treasure Island (FL): StatPearls Publishing

Copyright © 2023, StatPearls Publishing LLC.; 2023.

Izadi N, Eshrati B, Etemad K, Mehrabi Y, Hashemi-Nazari SS. Rate of the incidence of hospital-acquired infections in Iran based on the data of the national nosocomial infections surveillance. New Microbes New Infect. 2020;38:100768. DOI: 10.1016/j.nmni.2020.100768 PMID: 33093962

Pezhman B, Fatemeh R, Amir R, Mahboobeh R, Mohammad F. Nosocomial infections in an Iranian educational hospital: an evaluation study of the Iranian nosocomial infection surveillance system. BMC Infect Dis. 2021;21(1):1256. DOI: 10.1186/s12879-021-06948-1 PMID: 34911472

Moriyama K, Ando T, Kotani M, Tokumine J, Nakazawa H, Motoyasu A, et al. Risk factors associated with increased incidences of catheter-related bloodstream infection. Medicine (Baltimore). 2022;101(42):e31160. DOI: 10.1097/md.0000000000031160 PMID: 36281147

Rodríguez-Acelas AL, de Abreu Almeida M, Engelman B, Cañon-Montañez W. Risk factors for health care-associated infection in hospitalized adults: Systematic review and meta-analysis. Am J Infect Control. 2017;45(12):e149-e56. DOI: 10.1016/j.ajic.2017.08.016 PMID: 29031433

Babady NE. Hospital-Associated Infections. Microbiol Spectr. 2016;4(3). DOI: 10.1128/microbiolspec.DMIH2-0003-2015 PMID: 27337459

Khammarnia M, Ansari-Moghaddam A, Barfar E, Ansari H, Abolpour A, Setoodehzadeh F, et al. Systematic review and meta-analysis of hospital acquired infections rate in a middle east country (1995-2020). Med J Islam Repub Iran. 2021;35:102. DOI: 10.47176/mjiri.35.102 PMID: 34956948

Mehtarpour M, Takian A, Eshrati B, Jaafaripooyan E. Control of antimicrobial resistance in Iran: the role of international factors. BMC Public Health. 2020;20(1):873. DOI: 10.1186/s12889-020-09006-8 PMID: 32503497

Hashemzadeh M, Heydari R, Asareh Zadegan Dezfuli A, Saki M, Meghdadi H, Bakhtiyariniya P. Occurrence of Multiple-Drug Resistance Bacteria and Their Antimicrobial Resistance Patterns in Burn Infections from Southwest of Iran. J Burn Care Res. 2022;43(2):423-31. DOI: 10.1093/jbcr/irab097 PMID: 34236077

Monika P, Chandraprabha MN. Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients. Mol Biol Rep. 2022;49(6):4977-88. DOI: 10.1007/s11033-022-07160-3 PMID: 35107737

Pakzad I, Zayyen Karin M, Taherikalani M, Boustanshenas M, Lari AR. Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients. GMS Hyg Infect Control. 2013;8(2):Doc15. DOI: 10.3205/dgkh000215 PMID: 24327941

Emami A, Pirbonyeh N, Keshavarzi A, Javanmardi F, Moradi Ghermezi S, Ghadimi T. Three Year Study of Infection Profile and Antimicrobial Resistance Pattern from Burn Patients in Southwest Iran. Infect Drug Resist. 2020;13:1499-506. DOI: 10.2147/idr.s249160 PMID: 32547119

Perween N, Prakash SK, Siddiqui O. Multi Drug Resistant Klebsiella Isolates in Burn Patients: A Comparative Study. J Clin Diagn Res. 2015;9(9):Dc14-6. DOI: 10.7860/jcdr/2015/13837.6576 PMID: 26500905

Kabanangi F, Joachim A, Nkuwi EJ, Manyahi J, Moyo S, Majigo M. High Level of Multidrug-Resistant Gram-Negative Pathogens Causing Burn Wound Infections in Hospitalized Children in Dar es Salaam, Tanzania. Int J Microbiol. 2021;2021:6644185. DOI: 10.1155/2021/6644185 PMID: 34306091

Chaudhary NA, Munawar MD, Khan MT, Rehan K, Sadiq A, Tameez-Ud-Din A, et al. Epidemiology, Bacteriological Profile, and Antibiotic Sensitivity Pattern of Burn Wounds in the Burn Unit of a Tertiary Care Hospital. Cureus. 2019;11(6):e4794. DOI: 10.7759/cureus.4794 PMID: 31396464

Gupta M, Naik AK, Singh SK. Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon. 2019;5(12):e02956. DOI: 10.1016/j.heliyon.2019.e02956 PMID: 31886427

Baserisalehi N, Emami A, Pirbonyeh N, Javanmardi F. Bacterial infection pattern in ventilated burn patients in the southwest of Iran. Int J Mol Clin Microbiol. 2021;11(1):1410-5.

Sánchez M, Herruzo R, Marbán A, Araujo P, Asensio MJ, Leyva F, et al. Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients. J Burn Care Res. 2012;33(3):386-92. DOI: 10.1097/BCR.0b013e318231df95 PMID: 21979841

Sen S, Johnston C, Greenhalgh D, Palmieri T. Ventilator-associated pneumonia prevention bundle significantly reduces the risk of ventilator-associated pneumonia in critically ill burn patients. J Burn Care & Research. 2016;37(3):166-71. DOI: 10.1097/BCR.0000000000000228 PMID: 25501774

Ghanavati R, Darban-Sarokhalil D, Navab-Moghadam F, Kazemian H, Irajian G, Razavi S. First report of coexistence of AmpC beta-lactamase genes in Klebsiella pneumoniae strains isolated from burn patients. Acta microbiologica et immunologica Hungarica. 2017;64(4):455-62. DOI: 10.1556/030.64.2017.028 PMID: 28859497

Ahanjan M, Naderi F, Solimanii A. Prevalence of Beta-lactamases genes and antibiotic resistance pattern of Klebsiella pneumoniae isolated from teaching hospitals, Sari, Iran, 2014. Journal of Mazandaran University of Medical Sciences. 2017;27(149):79-87.

Emami A, Pirbonyeh N, Keshavarzi A, Javanmardi F, Ghermezi SM, Ghadimi T. Three year study of infection profile and antimicrobial resistance pattern from burn patients in southwest Iran. Infection and drug resistance. 2020;13:1499. DOI: 10.2147/IDR.S249160 PMID: 32547119

Azimi L, Alaghehbandan R, Asadian M, Alinejad F, Lari AR. Multi-drug resistant Pseudomonas aeruginosa and Klebsiella pneumoniae circulation in a burn hospital, Tehran, Iran. GMS hygiene and infection control. 2019;14.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.